Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -44.89 | N/A |
| PEG Ratio (TTM) | -0.43 | N/A |
| P/S Ratio (TTM) | 0.15 | N/A |
| P/B Ratio (TTM) | 0.71 | N/A |
| P/FCF Ratio (TTM) | 32.50 | N/A |
| Price to 5YR AVG Earnings Ratio | 3.57 | N/A |
| Price to 5YR AVG FCF Ratio | 6.43 | N/A |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.36% | N/A |
| ROE (TTM) | -1.59% | N/A |
| Net Profit Margin (TTM) | -0.32% | N/A |
| ROIC 5YR AVG | 11.37% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 112.37% | 49.65% | 21.19% |
| Revenue | -1.10% | 31.80% | 19.58% |
| Net Income | 111.09% | 94.14% | 47.63% |
| Cash Flow | -558.36% | 1,236.23% | 398.62% |
Health (14%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.28 | N/A |
| Quick Ratio (TTM) | 0.31 | N/A |
| D/E Ratio (TTM) | 2.40 | N/A |
| Interest Coverage (TTM) | 1.12 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 1.65 | N/A |
| LTL to 5YR AVG FCF | 13.35 | N/A |
| Shares Outstanding Growth 5YR AVG | 22.09% | N/A |